performance of dialysis units, and to compare the performance of one dialysis unit with that of another. Background. The UK Renal Registry quotes a 1-year death rate for patients established on dialysis of 19.4
EMBASE databases using search terms defined in the degrees of freedom. Where heterogeneity across studies was found, data were then pooled using a random effects model Appendix. The searches were limited to English articles, published between 1991 and 1998 inclusive. Papers were (r) [34] to allow for variation in relative risk between studies.
Only those results from multifactorial analyses were excluded if the sample size was less than 500 (an arbitrarily chosen cut-off ), or if the sample size was not stated in the pooled, as confounding was expected to have been well controlled in such analyses. We did not pool data on age abstract: 23 articles were found [6, . Of these, one had been cited in the RASD [6 ] , and a further five papers were when treated as a categorical variable, as each of the studies reviewed had used different age categories. Two studies [7, 13] immediately excluded, there being no quantitative estimates of relative risk [27] , no comparison of patients with and gave several measures of relative risk according to varying severity of comorbidity; all of these measures of relative risk without comorbidity [28, 31] , or no survival analysis of dialysis patients [32] . One study [21] was excluded because were included in the pooled estimates.
Finally, a meta-regression analysis was carried out to it was based on patients with end-stage lupus nephritis only. Hence, alongside the seven RASD papers, 17 newly identified investigate whether any marked heterogeneity could be explained by study covariates, namely whether incident or papers are considered in this review. Six papers cited in the RASD were not identified by the search strategy either prevalent cases were studied, whether data were drawn from an existing database or specifically collected for the study, because they were not identified by the search terms used [7] [8] [9] , or in spite of being identified by the search terms, the the country of study, the effect of inferring the standard error of a relative risk estimate from its associated P value, sample size was less than 500 [4, 6, 10] . and the method of classifying diabetes. Meta-regression was carried out using an iterative procedure, restricted maximum likelihood [35] .
Data extraction and pooling of data
Data on the modulating effects of age, diabetes and other Assessing possible sources of error in the pooled comorbidity were extracted from the text and tables of the estimates of risk selected papers. To estimate relative risk of death, according to the patient characteristics of interest, data were pooled, We carried out a regression asymmetry test [36 ] ( Egger's firstly across the RASD papers and then across the 17 test), using STATA, to look for publication bias in the data. retained papers identified in the literature search. Finally, The concept behind this test is that, if we assume that all pooled estimates of risk were derived for all papers combined. studies in the analysis are estimating the same true effect, we Initially, data were pooled using a fixed effects model (f ), would expect the study estimates to be distributed around which assumes that the relative risk from each study is an the unknown true estimate of risk, with a spread proportional estimate of the global relative risk of death. The method of to the study variance of each. That is, small studies would data pooling takes account of the quality of individual be spread widely around the estimated true risk, and larger studies, such that a larger study with a more precise estimate studies more narrowly around the true risk. Lack of symof risk contributes more to the pooled result than does a metry in such a distribution indicates the possibility that not smaller study with a less precise estimate. In brief, each all studies are represented in the analysis. By applying observed relative risk described in any study represents an regression techniques, Egger's test is a formal means of estimate of the true relative risk between, for example, a quantifying whether this is indeed the case. In Egger's test, patient with diabetes and one without diabetes. Each estim-the standardized effect estimate ( ln(RR)/se( ln(RR))) was ated relative risk is qualified by its standard error, which plotted against the precision of the estimate (1/se( ln(RR))), was either stated in the paper, estimated from the 95% and a variance-weighted regression line and confidence interconfidence interval ((upper limit-lower limit)/3.92), or val fitted. Failure of the confidence interval to include zero derived from a P value (P value of<0.001 was taken to be provides evidence of possible publication bias. Other possible P=0.001) and its associated z-score, whereby ln(RR)/z-sources of error were assessed qualitatively. score=se( ln(RR)). The larger the standard error, or variance (var(RR)=(se i ) [2] ) in study i, the less precise is the observed relative risk as an estimate of the true risk. It Results therefore follows that a less precise estimate should contribute less to the pooled estimate than a more precise relative risk.
Age
The information that each estimate contributes is defined as the inverse of the variance. The weight (w i ) given to each The papers cited in the RASD demonstrated an relative risk is equal to the information in this particular (i increase in relative risk of death for each year's increase [th] ) study divided by the sum of information across all n in age (pooled RR=1.025 (95% CI 1.018-1.032) (f )) studies. The weights clearly add to one. The pooled relative ( Tables 1 and 2 ). When data were pooled from all the risk estimate is the sum of the individual relative risks (on a logarithmic scale), each multiplied by its corresponding papers, the estimated relative risk was 1.029 (95% CI weight. If a single study estimate provides 10% of the 1.013-1.045) (r) (Figure 1 ). information, it also contributes 10% of its estimated relative A meta-regression analysis showed that a number risk to the pooled relative risk estimate. The information of study covariates were associated with the estimate was defined as the inverse of the study variance, and so, to of relative risk of death derived from pooling data obtain the variance of the pooled estimate, we take the from all the papers. The pooled relative risk estimate inverse of the total information.
for the studies based purely on incident patients was A test for heterogeneity across studies was carried out 1.024 (95% CI 1.006-1.042) (r), whilst those which using STATA [33] , to test the null hypothesis that the relative included prevalent cases gave rise to a significantly risk in each study is an estimate of the same global relative higher pooled estimate, 1.040 (95% CI 1.035-1.044) risk of death. Heterogeneity is said to be present if the test statistic lies at the extreme end of a x2 distribution on n-1 (r). Those studies that drew on routinely collected data had a higher relative risk of 1.032 (95% CI Gender 1.025-1.040) (r) than those in which data were col-Few of the papers provided information on the effects lected specifically for the study (RR=1.025 (95% CI of gender on mortality, hence it was not possible to 1.018-1.032) (f )). Those studies carried out in the provide separate analyses for mortality in men and USA demonstrated a lower relative risk of death women. associated with age (RR=1.025 (95% CI 1.012-1.039) (r)) than those carried out elsewhere (RR=1.042 (95% Diabetes CI 1.037-1.047) (r)). The inclusion of studies in which the standard error was inferred from a P value The relative risk associated with the presence of diabetes was found to be 1.76 (95% CI 1.33-2.32) (r) [17,26,29] and a study which had measured risk of death by each 10 year's increase in risk [15] increased from the RASD papers ( Tables 1 and 2 ), yet was somewhat higher, at 1.98 (95% CI 1.71-2.30) (r), when the relative risk of death: if these studies were excluded, the relative risk was 1.036 (95% CI 1.033-1.040) (r), data were also drawn from the studies identified in the literature search. Due to heterogeneity between studies, as compared to 1.029 (95% CI 1.013-1.045) (r) when included. a random effects model was used to pool data from ( Figure 2) . Some of the heterogeneity in the pooled estimate from all (f ) if both incident and prevalent cases were included in the sample, as compared to 1.70 (95% CI 1.55-1.86) the papers was explained by the use of incident or 
the presence of peripheral vascular disease (RR=1.38 for the study did not contribute to heterogeneity (95% CI 1.19-1.61) (f )). The estimated risk of death between studies. The relative risk of death associated was only slightly higher when drawing data from all with the presence of diabetes in the studies carried out the papers reviewed: Figure 3 demonstrates the relative in USA was 1.60 (95% CI 1.40-1.82) (f ), whilst it was risk of death due to the presence of heart disease 1.97 (95% CI 1.82-2.13) (f ) elsewhere. The use of (RR=1.59 (95% CI 1.49-1.69) (f )), and Figure 4 due standard errors inferred from P values, as compared to peripheral vascular disease (RR=1.58 (95% CI to those stated did not affect the pooled estimates of 1.29-1.93) (r)). The heterogeneity in the entire set of relative risk gained. studies addressing peripheral vascular disease was As shown in Table 2 , when assessing the relative risk partly explained by the use of prevalent or incident of death associated with diabetes, some studies comcases (P=0.013). The pooled estimate based on incidpared diabetics to non-diabetics. Other studies coment cases only was 1.43 (95% CI 1.26-1.62) (f ), whilst pared patients whose primary cause of renal failure the estimate was 2.66 (95% CI 1.66-4.28) (f ) in the was diabetic nephropathy to those whose renal remaining studies. Heterogeneity was partially explainfailure was caused by chronic glomerulonephritis or ed by the use of routine data sources (RR=1.43 another renal disease. The relative risk of death associ-(95% CI 1.26-1.62) (f )) as opposed to the use of data ated with diabetes as compared to non-diabetics was collected specifically for the study (RR=2.66 (95% CI 1.70 (95% CI 1.53-1.88) (f ). The relative risk was 1.66-4.28) (f )). The study location did not contribute higher, at 1.99 (95% CI 1.82-2.17) (f ), when patients to the heterogeneity between relative risk estimates. designated as having diabetic nephropathy were com-The fact that the standard errors associated with a pared to those with chronic glomerulonephritis. particular study's estimate of relative risk had to be inferred from a P value did contribute to some of the heterogeneity. Where the standard error was stated,
Other comorbidity
the pooled relative risk was 1.71 (95% CI 1.44-2.03) (f ), as compared to 1.30 (95% CI 1.10-1.54) (f ) in The relative risk of death associated with other comor-those studies in which a P value only was available. bid conditions is shown in Tables 1 and 3. Pooled Egger's test for publication bias did not indicate the estimates are given, but should be interpreted with presence of bias when applied to the data on relative caution due to variation in the definitions used for risk of death associated with age, diabetic status, or the presence of heart disease. classifying comorbidities within and between studies. aNo definition given. Presence or absence judged from clinical notes. bIn diabetics. cIn non-diabetics. dIncludes angina, acute myocardial infarction, pulmonary oedema, cerebrovascular accident, peripheral vascular disease; defined at time of registration; eCardiovascular disease includes all cardiac and arterial diseases with significant manifestations. 
Study selection bias

Discussion
Selection bias may have been introduced if the incluTo use the pooled relative risks obtained in this review sion of patients in a study cohort was associated with for predicting the risk of death on dialysis, we must one of the patient characteristics of interest, namely be confident of the validity of the studies from which age, diabetic status, or the presence of another comorthey were derived. It has been demonstrated that there bid condition. Such bias could arise both from was much heterogeneity between studies, indicating the characteristics of the database itself, and from the method by which patients were selected from the the presence of possible sources of error.
database for the purposes of any particular investi-the Cox proportional regression. The relative risk associated with age in this study is far lower than that gation. Regarding database characteristics, several sources of selection bias can be identified. Firstly, 20 in the other studies ( Figure 1) , due either to age being treated as categorical, or because the study was based of the studies drew data from existing databases or registries of patients ( Table 2) , and of these all but on diabetics only. This study contributed to the high degree of heterogeneity between relative risk estimates. two [5, 12] were carried out retrospectively, such that the authors did not control the nature of the data It is therefore appropriate to use a random effects model to pool the data on age. collected. Second, 18 of these 20 studies employed data from more than one dialysis centre, and only five There was confusion in many of the studies over whether diabetic status referred to diabetic nephro- [8, 9, 11, 20, 29] investigated between centre differences. Selection bias could therefore have been introduced, pathy as the primary cause of renal failure, or whether the same classification would be given to diabetics for example, by centres using different protocols for deciding the time at which to start maintenance dia-whose renal failure had another cause. Even in patients with incident ESRD, the presence of diabetes may or lysis, by whether or not acute dialysis patients were included on their database, or by the centre trans-may not imply that it had caused renal failure.
Similarly, none of the studies based on prevalent cases plantation policy. Third, some databases included only incident cases of ESRD, whereas others included pre-of ESRD reported the date of onset of diabetes in patients on dialysis, and hence it was not possible to valent as well as incident cases ( Table 2 ). The relative risks for age, diabetes, and comorbidity in studies distinguish patients who had had diabetes since the start of dialysis treatment from those with later onset. based on prevalent cases were higher than those based on incident cases. This suggests that the risk of death
In retrospective studies, particularly those involving many centres, it is likely that there will have been increases with time spent on dialysis, and may be due to the fact that patients on long-term dialysis have a variations between physicians in the diagnosis and recording of comorbid conditions. More valid data on gradual deterioration in health, or due to the fact that patients with a higher risk of death do not receive a comorbidity are available from prospective studies, such as Barrett et al. [13] in which the presence and transplant and hence are those who remain on dialysis. Fourth, according to the standard practice of the US severity of heart disease could be assessed at the time of onset of dialysis treatment. The variations in classiRenal Data System, two of the studies explicitly excluded patients who had died within the first 90 days fication of comorbidity between and within studies make the validity of pooling relative risks based on after the start of dialysis [7, 29] : it is likely that those who died earlier were older or burdened with more different definitions questionable, but is also an argument for the use of random effects models. Hence, the comorbidity. Finally, data quality will also have been affected by the method by which databases were pooled estimates of risk according to comorbidity should be interpreted with caution. In addition, comorupdated: whether they were modified continuously, or irregularly.
bid conditions were assessed at the start of dialysis and none of the studies took into account changes in Apart from selection bias in the database itself, further bias may have been introduced when patients the prevalence or severity of comorbidity over time.
The use of risk classification schemes meant that the were selected from databases or registries for inclusion in a study. For example, many studies excluded patients influences of age, diabetes, and comorbidity could not be independently assessed in some studies [8, 9] . who had transferred between dialysis units [7, 8, 10, 12, 16, 20, 22, 23, 25] , and some selected patients in Patient outcome misclassification bias specific age-groups only [5, 9, 20, 24] .
In five of the reviewed papers [4, 6, 13, 15, 19] , data The main source of error in dealing with outcome of were collected specifically for the study. However, these patients was the censoring of patients who received a were not free of selection bias. Patients with dementia, transplant. Seventeen of the studies stated that patients an age-related condition, were excluded in one [15] . were censored at transplantation, but none stated Another described only patients on CAPD [19] , and whether patients returned to the cohort if their graft the choice of treatment modality would almost cer-failed. Similarly, it was not stated if the patient was tainly have been influenced by the presence of comor-followed up until death with a functioning graft. Two bidities. Recruitment into a third study [4] was of the studies [11, 26 ] did not censor patients at transvoluntary, leading to only 40% of incident dialysis plantation, and five [4, 8, 9, 13 ,29] did not state how patients being included. In summary, each of the 24 transplantation was managed in the analysis. This lack reviewed papers contained at least one possible source of clarity may have led to misclassification of the of selection bias.
treatment modality: whether survival on both dialysis and transplantation or purely on dialysis was being Patient characteristics misclassification bias assessed.
Loss to follow-up may also have introduced bias. Misclassification bias may have been introduced with regard to patient characteristics, namely, age, diabetic Follow-up was near complete in 11 studies, likely to be near complete in three [8] [9] [10] , incomplete in five status and the presence of other comorbidities. For example, it was not clear in Medina et al. [15] whether [15, 19, 20, 24, 26 ] , and the number lost to follow-up was not stated in six [5, 6, 13, 16, 22, 28] . age was treated as a linear or categorical variable in Confounding sistency in the evidence from the studies, and the strength of the associations is clear. The observed association between age, diabetes or It would be of interest to investigate the relationship other comorbidity, and the risk of death may have between severity of comorbidity and death; however, been confounded by the presence of another variable this was not possible from the papers identified. which was associated with both the patient character-Similarly, none of the studies addressed whether there istics of interest and the risk of death on dialysis. was interaction between comorbid conditions, that is, Potential confounders may have been introduced due whether the presence of two comorbid conditions had to the characteristics of different dialysis centres, such a synergistic effect on the risk of death. as the frequency of dialysis given, the dialysis modality preferred (haemodialysis or continuous ambulatory peritoneal dialysis), the time at which dialysis treatment Conclusion was typically initiated in a patient, or the rate of transplantation at a particular centre. The influence of As efforts are made to control increasing health-care such confounders would be expected to be greater if costs, medical practice is understandably coming under the time period over which patients were enrolled closer and closer scrutiny. The performance of indispanned many years [7, 10] , as there might be system-vidual doctors and units are being compared one with atic changes in the treatment regimens offered. another. Interested groups, such as the UK Renal Confounding may also have been introduced by differ-Association, are being asked to contribute to the ences in unmeasured patient characteristics, such as definition of standards. In this study papers identified social class or race.
by a systematic literature search have been used to The studies examined demonstrate many attempts quantify the effect of age, diabetes and other comorbidto control for confounding. Some samples were ity on the survival of dialysis patients. This is crucial restricted to one dialysis centre [6, 10, 20] , or a short 'background information' which could allow adjustperiod of time, such as 3 years [15] . Others controlled ment to be made for variation in case mix when for centre differences by analysing data separately for comparing the performance of individual dialysis units different dialysis centres [8, 9] . Change in treatment with national and international standards, and when regimens over time was controlled by stratifying for comparing the performance of one dialyis unit with time of entry into the study [7, 10] . In the main, that of another. however, confounding was controlled by way of multiHowever, our systematic overview of the literature factorial analysis. In particular, two centres controlled demonstrates that comparisons of survival of dialysis for a centre effect in the multifactorial analysis [11, 29] . patients in different centres will always be difficult if We drew only on estimates of risk derived from multi-data collection is not standardized. But we recognize factorial analyses for the purposes of obtaining pooled that the recommendation of standards is always a estimates of risk.
perilous and subjective matter. None can claim the There is some concern that studies using a logistic right to set them. In this context, some might suggest regression analysis instead of Cox proportional hazards the collection of a complex data set, whereas those of regression did not fully control for the fact that patients a more pragmatic nature (such as ourselves) would had spent different amounts of time in the study cohort favour something relatively simple. Whilst not wishing [12, 13] . In addition, the proportional hazards assump-to dissuade those of a more ambitious disposition, we tion was tested in only four of the studies that used would suggest that all dialysis units be encouraged to this method of analysis [4, 9, 15, 24] . If the assumption keep records of the following characteristics of all was found not to hold in the remaining studies, con-incident chronic dialysis patients: date of first dialysis, founding may have been inadequately controlled: there age, sex, diabetes mellitus as a cause of renal failure may have been a decay in the effect of baseline pro-(yes/no), clinical evidence of heart disease on history, gnostic factors on relative risk over time, or there may examination or simple testing (yes/no), clinical evidhave been non-proportionality in times to peak hazard. ence of peripheral vascular disease on history, examinaIn addition, it is possible that variation in the methods tion or simple testing (yes/no), date of transplantation by which multifactorial models were constructed (e.g. or death. by a stepwise method, or by including known con-
